Alteration of tight junctions in pulmonary microvascular endothelial cells in bleomycin-treated rats

Experimental and Toxicologic Pathology

Volumn 64, Issue 1-2, 2012, Pages 81-91

  Yin, Qian ^a   Nan, Haiyan ^a   Yan, Linfeng ^a   Huang, Xiaofeng ^b   Wang, Wei ^a   Cui, Guangbin ^a   Wei, Jingguo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Paracellular barrier function; Pneumococcal pneumonia; Pulmonary fibrosis; Pulmonary microvascular endothelial cells (PMVECs); Tight junction; Zonula occludens 1 (ZO 1)

Indexed keywords

BLEOMYCIN; PROTEIN ZO1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL INFILTRATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SWELLING; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOPATHOLOGY; LUNG FIBROSIS; MACROPHAGE ACTIVATION; MALE; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; STREPTOCOCCUS PNEUMONIA; TIGHT JUNCTION;

ANIMALS; BLEOMYCIN; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CELL COUNT; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; LUNG; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MICROVESSELS; PHOSPHOPROTEINS; PNEUMONIA, PNEUMOCOCCAL; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; TIGHT JUNCTIONS;

ANIMALIA; RATTUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84857640572     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.06.010     Document Type: Article

References (41)

1. Arai S., Gohara Y., Akashi A., Kuwano K., Nishimoto M., Yano T., et al. Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters. Antimicrob Agents Chemother 1993, 37:287-292.
2. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007, 204:2349-2362.
3. Bedos J.P., Azoulay-Dupuis E., Moine P., Muffat-Joly M., Veber B., Pocidalo J.J., et al. Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy. J Pharmacol Exp Ther 1998, 286:29-35.
4. Biswas P., Canosa S., Schoenfeld D., Schoenfeld J., Li P., Cheas L.C., et al. PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. Am J Pathol 2006, 169:314-324.
5. Daffara R., Botto L., Beretta E., Conforti E., Faini A., Palestini P., et al. Endothelial cells as early sensors of pulmonary interstitial edema. J Appl Physiol 2004, 97:1575-1583.
6. Dewever J., Frerart F., Bouzin C., Baudelet C., Ansiaux R., Sonveaux P., et al. Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. Am J Pathol 2007, 171:1619-1628.
7. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
8. Everett R.S., Vanhook M.K., Barozzi N., Toth I., Johnson L.G. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol 2006, 69:492-500.
9. Fang K.C. Mesenchymal regulation of alveolar repair in pulmonary fibrosis. Am J Respir Cell Mol Biol 2000, 23:142-145.
10. Fanning A.S., Jameson B.J., Jesaitis L.A., Anderson J.M. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998, 273:29745-29753.
11. Gumbiner B. Structure, biochemistry, and assembly of epithelial tight junctions. Am J Physiol 1987, 253:C749-758.
12. Gumbiner B., Lowenkopf T., Apatira D. Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc Natl Acad Sci USA 1991, 88:3460-3464.
13. Hermanns M.I., Unger R.E., Kehe K., Peters K., Kirkpatrick C.J. Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab Invest 2004, 84:736-752.
14. Jiang M., Jin Y., Liu Y., Yu Z., Liu P., Dong R. Culture of microvascular endothelial cells. J Pract Stomatol 2004, 20:24-26.
15. Kaiho M., Ichikawa A. An application of the ferrocyanide-reduced osmium tetroxide for the ultrastructural analysis of gerbil Harderian gland. J Electron Microsc (Tokyo) 1982, 31:410-414.
16. Kasai H., Allen J.T., Mason R.M., Kamimura T., Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 2005, 6:56.
17. Kawkitinarong K., Linz-McGillem L., Birukov K.G., Garcia J.G. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am J Respir Cell Mol Biol 2004, 31:517-527.
18. King J., Hamil T., Creighton J., Wu S., Bhat P., McDonald F., et al. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 2004, 67:139-151.
19. Lee D.B., Huang E., Ward H.J. Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 2006, 290:F20-34.
20. Li J., Poovey H.G., Rodriguez J.F., Brody A., Hoyle G.W. Effect of platelet-derived growth factor on the development and persistence of asbestos-induced fibroproliferative lung disease. J Environ Pathol Toxicol Oncol 2004, 23:253-266.
21. Martin J., Collot-Teixeira S., McGregor L., McGregor J.L. The dialogue between endothelial cells and monocytes/macrophages in vascular syndromes. Curr Pharm Des 2007, 13:1751-1759.
22. Middleton J., Americh L., Gayon R., Julien D., Mansat M., Mansat P., et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 2005, 206:260-268.
23. Mutsaers S.E., Foster M.L., Chambers R.C., Laurent G.J., McAnulty R.J. Increased endothelin-1 and its localization during the development of bleomycin-induced pulmonary fibrosis in rats. Am J Respir Cell Mol Biol 1998, 18:611-619.
24. Nishiyama R., Sakaguchi T., Kinugasa T., Gu X., MacDermott R.P., Podolsky D.K., et al. Interleukin-2 receptor beta subunit-dependent and -independent regulation of intestinal epithelial tight junctions. J Biol Chem 2001, 276:35571-35580.
25. Oikonomou N., Harokopos V., Zalevsky J., Valavanis C., Kotanidou A., Szymkowski D.E., et al. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS One 2006, 1:e108.
26. Okada H., Danoff T.M., Kalluri R., Neilson E.G. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997, 273:F563-574.
27. Oku H., Shimizu T., Kawabata T., Nagira M., Hikita I., Ueyama A., et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 2008, 590:400-408.
28. Pacanowski M.A., Amsden G.W. Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis. Ann Pharmacother 2005, 39:1678-1686.
29. Petri B., Bixel M.G. Molecular events during leukocyte diapedesis. FEBS J 2006, 273:4399-4407.
30. Pulichino A.M., Wang I.M., Caron A., Mortimer J., Auger A., Boie Y., et al. Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis. Am J Respir Cell Mol Biol 2008, 39:324-336.
31. Rijcken E., Mennigen R.B., Schaefer S.D., Laukoetter M.G., Anthoni C., Spiegel H.U., et al. PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G446-452.
32. Sawa Y., Sugimoto Y., Ueki T., Ishikawa H., Sato A., Nagato T., et al. Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. J Histochem Cytochem 2007, 55:721-733.
33. Shi-wen X., Kennedy L., Renzoni E.A., Bou-Gharios G., du Bois R.M., Black C.M., et al. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum 2007, 56:4189-4194.
34. Stamatovic S.M., Keep R.F., Kunkel S.L., Andjelkovic A.V. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci 2003, 116:4615-4628.
35. Tashiro M., Izumikawa K., Yoshioka D., Nakamura S., Kurihara S., Sakamoto N., et al. Lung fibrosis 10 years after cessation of bleomycin therapy. Tohoku J Exp Med 2008, 216:77-80.
36. Utech M., Bruwer M., Nusrat A. Tight junctions and cell-cell interactions. Methods Mol Biol 2006, 341:185-195.
37. Vaillant P., Menard O., Vignaud J.M., Martinet N., Martinet Y. The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis 1996, 51:145-152.
38. Van Itallie C.M., Anderson J.M. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006, 68:403-429.
39. Warshamana G.S., Pociask D.A., Fisher K.J., Liu J.Y., Sime P.J., Brody A.R. Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice. Int J Exp Pathol 2002, 83:183-201.
40. Xie L., Law B.K., Chytil A.M., Brown K.A., Aakre M.E., Moses H.L. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 2004, 6:603-610.
41. Zeisberg M., Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004, 82:175-181.